论文部分内容阅读
现任社会兼职 1.世界卫生组织国际癌症研究机构“国际肿瘤分子分型工作委员会”主席 2．国际EB病毒及相关疾病协会副理事长 3．中国抗癌协会、副理事长 4．广东省医学会常务理事 5．国家药监局新药评审专家 6．第八届国家药典委员会委员 7．《癌症》杂志(核心期刊、Medling/Index Medicus收录)主编 8．《中国科学》(生命科学)责任编委 9．美国《Cancet Biology and Therapy》杂志编委 10．美国《Cell Cycle》杂志常务编委 11美国《Journal of Translational Medicine》杂志亚洲区编委院士简介曾益新,男,1962年出生,1985年湖南衡阳医学院本科毕业,1990年中山大学(原中山医科大学)博士毕业。 1992-1997年留学日本、美国。1997年2月回国工作, 被聘为中山医科大学教授、博士生导师及肿瘤防治中心副主任、肿瘤研究所所长,同年10月担任肿瘤防治中心主任及肿瘤医院院长(兼任实验研究部主任和生物治疗中
Current social part-time 1. World Health Organization International Agency for Research on Cancer “international tumor molecular typing committee” chairman 2. International EB virus and related diseases association vice chairman 3. Chinese anti-cancer Association, vice chairman 4. Guangdong Provincial Medical Association executive director 5. State Drug Administration drug review experts 6. Eighth Committee of the State Pharmacopoeia 7. Chief Editor of Cancer (core journal, Medling / Index Medicus) 8. China Science (Life Sciences) Editorial Board of Responsibilities 9. Editorial Board of the U.S. “Cancet Biology and Therapy” magazine. American “Cell Cycle” magazine executive editor 11 United States “Journal of Translational Medicine” magazine editor in chief of Asia editorial board Zeng Yi new, male, born in 1962, 1985 Hunan Hengyang Medical College graduate, 1990 Zhongshan University (formerly Zhongshan Medical University Ph.D. 1992-1997 study in Japan, the United States. Returned to China in February 1997, was hired as a professor of Zhongshan Medical University, doctoral tutor and deputy director of cancer prevention and treatment center, director of the Institute of Oncology in October the same year as director of Cancer Center and Cancer Hospital Dean (concurrently director of experimental research department And biological treatment